What are Our Goals at Plus Therapeutics?

(1:25)

Plus Therapeutics CEO Dr. Marc Hedrick - Cancer's Hardest Problems (Clip)

(1:37)

Plus Therapeutics at the NYSE with IPO Edge

(11:33)

Plus Therapeutics (Nasdaq: PSTV) Annual Stockholder Meeting

(15:30)

Emerging Novel Diagnostic and Therapeutic Approaches for Leptomeningeal Metastases

(1:3:51)

Plus Therapeutics at the Benzinga Virtual Healthcare Summit

(8:40)

Who is Plus Therapeutics?

(31)

Dr. Marc Hedrick, President \u0026 CEO, Plus Therapeutics - The Plus Side: Making groundbreaking devel...

(28:43)

\

(54:7)

“The Buzz'' Show: Plus Therapeutics (NASDAQ: PSTV) Awarded USD 17.6 Million from State of Texas

(41)

What Initially Piqued Plus Therapeutics' Interest in 186RNL?

(48)

How Does Plus Therapeutics Think About Glioblastoma?

(52)

Plus Therapeutics Strengthens Commercial RNL Supply Chain with 10-Year Exclusivity Agreement

(40)

Plus Therapeutics tackles the hardest problems in cancer with targeted radio therapeutics

(8:22)

Plus Therapeutics Successfully Treats First Patient in Cohort 8 of ReSPECT-GBM Phase 1/2a Trial

(1:4)

16 Years of Jacknjellify! 🎂 (Music Video)

(2:39)

Overview of Illumina Sequencing by Synthesis Workflow | Standard SBS chemistry

(5:13)

biogen pharmachem industries Ltd share | biogen pharmachem industries ltd share latest news

(3:12)

Plus Therapeutics Significantly Expands Investigational Oncology Drug Pipeline

(1:16)

Fireside Chat with Plus Therapeutics CEO

(58:10)

Plus Therapeutics' ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases

(2:47)